Search
Now showing items 1-1 of 1
Treatment Response to Imatinib Among Chronic Myeloid Leukemia Patients as Seen in Nairobi
(University of Nairobi,, 2010)
Background: Imatinib (Glivec/Gleevec) therapy has improved outcomes in chronic myeloid leukaemia (CML) in the last 10 years. It is an expensive drug. In Kenya, over 250 patients with CML access the medication via GIPAP ...